A Cohort Study to Evaluate the Risk of Hospitalisation for Congestive Heart Failure Associated with the Use of Aclidinium and Other Chronic Obstructive Pulmonary Disease Medications in the UK Clinical Practice Research Datalink.
Cristina RebordosaEstel PlanaAnnalisa RubinoJaume AguadoAlejhandra LeiSami DaoudNuria Saigi-MorguiSusanna Perez-GutthannElena Rivero-FerrerPublished in: International journal of chronic obstructive pulmonary disease (2021)
The study did not find increased risks of hospitalisations for heart failure in new users of aclidinium, tiotropium, other LAMAs, LAMA/LABA, and LABA/ICS compared with LABA.